Valeritas Holdings Inc. Receivables Turnover Ratio (VLRX), from the third quarter 2019 to the third quarter 2018 current and historic results, rankings and more - CSIMarket
CSIMarket Company Name, Ticker, Customers, else..
 


• Sales per Employee
• Income per Employee
• Inventory Turnover
• Asset Turnover
• Receivables Turnover
Valeritas Holdings Inc.  (VLRX)
 

Valeritas Holdings Accounts Receivables Turnover Ratio from the third quarter 2019 to the third quarter 2018

Quarterly Results, Trends, Rankings, Statistics


Valeritas Holdings Inc.'s ability to collect its outstanding accounts receivable from its corporate clients, has improved in the third quarter 2019 to a ratio of 4.86, above the company average. This is a clear sign of healthy business climate in the Medical Equipment & Supplies industry and improving liquidity at their respective customers, during the third quarter 2019. Average receivable collection period, for the Valeritas Holdings in Sep 30 2019 quarter, has decreased to 75 days, compared to 77 days, in the Jun 30 2019 quarter.

If we take a look into Healthcare sector 397 other companies have achieved higher receivables turnover ratio. While total ranking has deteriorated relative to the period ending Sep 30 2019 from 2102 to 2975.

What is Receivable Turnover Ratio?
What is Valeritas Holdings Inc. Selling?


What is Receivable Turnover Ratio?




Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

VLRX Receivables Turnover Ratio (Sep 30 2019)
III. Quarter		 (Jun 30 2019)
II. Quarter		 (Mar 31 2019)
I. Quarter		 (Dec 31 2018)
IV. Quarter		 (Sep 30 2018)
III. Quarter
Y / Y Receivable Change 14.64 % 16.15 % 36.35 % 48.69 % 41.99 %
Y / Y Revenue Change 22.19 % 15.65 % 5.3 % 19.25 % 36.74 %
Receivable Turnover Ratio (TTM) 4.86 4.77 4.76 5.04 5.35
VLRX's Total Ranking # 2975 # 2102 # 2103 # 2103 #
Accounts Receivable average collection period days 75 77 77 72 68
Seq. Receivable Change 13.71 % -1.29 % -9.12 % 12.39 % 15.2 %
Seq. Revenue Change 12.63 % 17.35 % -7.12 % -0.46 % 6.6 %


Receivable Turnover Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 128
Healthcare Sector # 398
Overall Market # 2975

Receivable Turnover Ratio Statistics
High Average Low
5.51 3.84 0
(Mar 31 2018)   (Dec 31 2016)





VLRX Company Profile • Back to VLRX Efficiency Comparisons • Compare VLRX Receivables Turnover Ratio to its Competitors

Financial Statements
Valeritas Holdings's Accounts Receivable $ 6 Millions Visit VLRX's Balance sheet
Valeritas Holdings's Sales TTM $ 29 Millions Visit VLRX's Income Statement
Sources of VLRX's Revenues Visit VLRX's Sales by Geography

Other Accounts Receivable Turnover Ratios
Medical Equipment & Supplies Industry Accounts Receivable Turnover Trends and Statistics
Healthcare Sector Accounts Receivable Turnover Statistics
Accounts Receivables Turnover Trends for overall market
VLRX's Receivable Turnover Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and total Market
Highest Ranking Accounts Receivables Turnover
Lowest Ranking Accounts Receivables Turnover

You may also want to know
VLRX's Growth Rates VLRX's Roa VLRX's Inventory Turnover Ratio VLRX's Dividend Comparisons
VLRX's Profitability Ratios VLRX's Roi VLRX's Asset Turnover Ratio VLRX's Dividend Growth
VLRX's Valuation Ratios VLRX's Roe VLRX's Financial Strength Ratios VLRX's Dividend Payout Ratio



Companies with similar Receivables Turnover Ratio for the quarter ending Sep 30 2019, within Healthcare Sector Receivable Turnover Ratio Revenues for 12 Months ending Sep 30 2019 Receivable at quarter ending Sep 30 2019
Parallax Health Sciences Inc   12.51 $ 0.079  Millions$ 0.006  Millions
Tvardi Therapeutics Inc   12.36 $ 20.908  Millions$ 1.691  Millions
Telesis Bio Inc   12.29 $ 4.152  Millions$ 0.338  Millions
La Jolla Pharmaceutical Company  11.95 $ 19.988  Millions$ 1.673  Millions
Zynex inc   11.84 $ 40.647  Millions$ 3.433  Millions
Integrated Biopharma Inc  11.83 $ 51.079  Millions$ 4.317  Millions
Arvinas Inc   11.78 $ 41.523  Millions$ 3.526  Millions
Exact Sciences Corporation  11.75 $ 723.699  Millions$ 61.609  Millions
Rigel Pharmaceuticals Inc  11.73 $ 82.632  Millions$ 7.044  Millions
Karyopharm Therapeutics Inc   11.73 $ 23.242  Millions$ 1.982  Millions
The Pennant Group Inc   11.69 $ 88.398  Millions$ 7.562  Millions
Travere Therapeutics Inc   11.61 $ 172.421  Millions$ 14.856  Millions
Lifeloc Technologies Inc   11.58 $ 8.715  Millions$ 0.752  Millions
Teladoc Health Inc   11.37 $ 561.871  Millions$ 49.405  Millions
China Pharma Holdings Inc  11.09 $ 11.118  Millions$ 1.003  Millions
Scienture Holdings Inc   10.88 $ 7.034  Millions$ 0.647  Millions
Acorda Therapeutics Inc   10.81 $ 223.301  Millions$ 20.661  Millions
Tivity Health Inc   10.67 $ 1,011.405  Millions$ 94.826  Millions
Akebia Therapeutics Inc   10.52 $ 325.296  Millions$ 30.911  Millions
Glaukos Corp  10.51 $ 225.211  Millions$ 21.420  Millions
Catalyst Pharmaceuticals Inc   10.49 $ 72.684  Millions$ 6.931  Millions
Pediatrix Medical Group Inc   10.38 $ 5,353.433  Millions$ 515.950  Millions
Myomo Inc   10.28 $ 3.207  Millions$ 0.312  Millions
Procyon Corporation  10.26 $ 4.284  Millions$ 0.417  Millions
Rockwell Medical inc   10.20 $ 62.667  Millions$ 6.143  Millions
National Healthcare Corp  10.09 $ 991.423  Millions$ 98.244  Millions
Patterson Companies Inc   10.09 $ 5,580.846  Millions$ 553.306  Millions
Surmodics Inc   10.02 $ 100.077  Millions$ 9.987  Millions
Capricor Therapeutics inc   9.99 $ 1.431  Millions$ 0.143  Millions
Icagen, Inc.  9.95 $ 14.084  Millions$ 1.416  Millions

Date modified: 2026-08-29T14:51:08+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.